| CPC A61K 8/60 (2013.01) [A61K 8/44 (2013.01); A61Q 5/00 (2013.01); A61Q 19/007 (2013.01); A61Q 19/08 (2013.01)] | 22 Claims |
|
1. A method of improving skin barrier function in a subject, wherein said method comprises topically administering a composition of ambroxol in a controlled-release formulation, wherein said controlled release formulation doses said subject at a rate to maintain a concentration of less than 0.1% (w/w) of ambroxol in solution, and wherein said improvement in skin barrier function is measured by:
1) a reduction in the signs of aging (or premature aging),
2) a decrease in the aging process of the skin,
3) a reduction in the appearance of lines and/or wrinkles,
4) a decrease in skin sagging,
5) an improvement and/or promotion in skin elasticity or suppleness,
6) a reduction in sun damage,
7) a reduction in stretch marks,
8) a reduction in the appearance of scars,
9) a reduction in the appearance of burns,
10) a reduction in the appearance of blemishes (e.g. acne),
11) a reduction in the appearance of dark circles,
12) a reduction in the appearance of age spots,
13) a reduction in the appearance of puffiness,
14) a prevention in water loss of the skin, and/or
15) an increase in moisturization.
|